Purpose and Scope of the Package
A DMC data package is the organized set of materials prepared to support a committee’s review at a defined interim point. Its job is to make the information relevant to that review complete, traceable, and consistent across displays. It is not a substitute for the DMC’s judgment, and assembling it does not authorize changing an endpoint, analysis population, or review question after seeing interim results.
The starting point is the validated interim snapshot: the fixed, documented data cut from which the package is produced. Package builders should preserve its identity and use the approved review plan and charter to determine which materials belong in the review. The package should make clear what data are included, what time period they cover, and which audience may receive each item. A polished layout cannot correct an unclear data cut, an inconsistent denominator, or an unintended disclosure.
The package’s exact contents depend on the trial and the DMC’s remit. The inclusion of a display does not, by itself, imply that a finding is clinically important or that a recommendation should follow. Those are matters of review, not document assembly. The focus here is how to build and quality-check the collection so its contents can be reviewed as intended.
Build From a Defined Package Plan
Before producing tables or figures, create a package plan that maps each review question to a display, its source, its population, its time window, and its intended audience. This step prevents a common failure: producing a large collection of available outputs without confirming that it answers the questions the DMC was asked to review.
Record the trial, review date, data-cut date and time where relevant, snapshot identifier, package version, and responsible production roles. Use the same identifiers throughout the contents list and display footers.
List the required sections and displays, their prespecified definitions, and whether each is for an open or restricted audience, as applicable under the governance plan.
Use the approved snapshot, documented derivation rules, and validated programs. Do not silently substitute a later extract or revise definitions to improve the appearance of results.
Check counts, denominators, labels, dates, footnotes, and display-to-display consistency. Record discrepancies and their resolution rather than correcting them without trace.
Confirm that the final files match the approved audience and package version, and retain the supporting production and quality-control record.
A package plan is useful even when the final set is short. It distinguishes required materials from optional context, and allows reviewers to see whether an expected display is absent rather than assuming it was overlooked. If a planned display cannot be produced, state that fact and its reason; do not leave a silent gap.
Core Displays and Their Reconciliation
Trial-status material gives the committee a compact operational context: for example, the enrollment target, participants enrolled to the cut, sites open or closed, and relevant follow-up status. Each count needs a definition and a reference date. “Enrolled” should not be used interchangeably with “randomized,” “treated,” or “completed.” Where the trial uses multiple arms or stages, the display should make the grouping clear while respecting the audience rules.
Participant disposition accounts for what happened to participants from a stated starting population through the relevant milestones. The categories should be mutually exclusive when presented as a partition, and counts should reconcile. For a simple flow from randomized participants to current status, the basic check is:
This identity applies only when the three status categories are exhaustive, mutually exclusive, and defined at the same cut. If participants can have more than one reason for discontinuation, the number of reasons is not expected to sum to the number of discontinued participants; label those reason counts as potentially overlapping. Similarly, a disposition table based on treated participants must not be presented as if its denominator were all randomized participants.
Worked Example: Reconciling Participant Disposition
Suppose a hypothetical trial snapshot contains 240 randomized participants. At the cut, 126 have completed the defined follow-up, 18 have discontinued, and 96 remain in follow-up. Check the flow and calculate the percentages of randomized participants in each status.
The counts sum to \(126+18+96=240\), so the three categories reconcile to the randomized total. Because they are stated as the complete status categories at one cut, the displayed percentages use 240 as the denominator.
The percentages sum to 100.00%. A suitable display would state “status among 240 randomized participants at the interim cut,” rather than leaving the denominator or time point implicit. If the discontinuation reasons were, for example, 10 by participant choice and 11 for another reason, those reason counts could sum to more than 18 if a participant could have multiple recorded reasons; the table would need to say so.
Protocol-deviation material should identify the classification rules and reporting window used. Useful fields can include deviation category, date or period, affected participant count, and whether the deviation was considered important under the trial’s prespecified definitions. Counts of deviations and counts of participants with at least one deviation are different quantities. If one participant has two deviations, a deviation-event count can exceed the participant count; the table must name which quantity it reports.
Worked Example: Reporting Deviations With the Correct Denominator
In a hypothetical trial, 120 participants have been randomized by the cut. The reviewed deviation log contains 15 deviations affecting 9 distinct participants. Of those 9 participants, 6 had at least one deviation classified as important under the protocol’s stated rule. Show how to report the participant-level proportions.
The denominator for “participants with at least one deviation” is 120 randomized participants, not 15 deviation records. The proportion is \(9/120=0.075\), or 7.500%. The proportion with at least one important deviation is \(6/120=0.050\), or 5.000%.
The display should also state that there were 15 deviation records, because that is a different count. These figures are internally consistent: 9 distinct participants can account for 15 records, and 6 participants with an important deviation can be a subset of those 9. Nothing in these counts alone establishes the impact of the deviations on trial conclusions.
Safety and Efficacy Materials
Safety summaries should use the definitions, time windows, groupings, and denominators specified for the review. At a package-assembly level, confirm that labels distinguish participants from events, that the observation period is explicit, and that the source population is clear. A participant may experience multiple events, so a total event count is not generally a count of unique participants. The detailed interpretation of safety listings and summaries belongs to the committee’s review, not to the act of packaging.
Efficacy displays should likewise follow prespecified endpoints, analysis populations, visit or follow-up definitions, and presentation conventions. The package plan should identify each display and its provenance; the package builder should not select a more favorable endpoint, add an unplanned subgroup, or change a time point because a different view appears more informative after looking at the data. If a planned output is unavailable or a prespecified analysis cannot be completed, disclose the limitation clearly.
Every display benefits from a concise caption or footnote stating the population, data cut or observation window, units, and any non-obvious denominator or derivation. Include a contents list and a package-level note that identifies the snapshot and version. For any audience-specific set, check not only the file name but also the contents, metadata, and rendered output; a correct label does not prevent an incorrect version from being included.
Worked Example: Choosing Package Metadata for an Efficacy Display
A hypothetical review plan calls for a display of the prespecified primary outcome at the scheduled 12-week assessment, using the specified analysis population and the interim snapshot. The package builder notices that a 10-week output is available sooner. What should appear in the package?
The package should include the prespecified 12-week display if it can be produced from the approved data and analysis rules. Its caption should identify the primary outcome, the 12-week assessment, the analysis population, and the snapshot or cut. The 10-week output is not a substitute merely because it is available sooner: it uses a different time point and would answer a different question.
If the 12-week display cannot be produced, the package should identify it as unavailable and explain the operational reason. The builder should not silently replace it or imply that the alternate display satisfies the planned review. This preserves traceability and allows the DMC to judge the limitation within its mandate.
Quality Checks, Alternatives, and Limitations
A useful package-level quality check is to test both internal arithmetic and consistency between materials. For example, the randomized total in the status overview should agree with the disposition denominator when both refer to the same population and cut. Differences may be legitimate if definitions differ, but then those definitions should be explicit. A disagreement without an explanation is a quality issue, not a matter for readers to guess through.
The reconciliation identity above follows directly from the partition of the population. If every randomized participant belongs to exactly one of completed, discontinued, or ongoing status at the cut, the sets are disjoint and their union is the randomized population. Therefore, the size of the whole equals the sum of the sizes of its parts. If the sum fails, at least one count, category definition, or population alignment is wrong or incomplete. This is why reconciliation is a substantive check, not merely a formatting preference.
Common diagnostics include:
- Verify that each count has a named population, denominator, date, and unit where relevant.
- Recalculate sums and percentages from the displayed counts, allowing only stated rounding differences.
- Compare shared totals across status, disposition, deviation, and other sections when definitions match.
- Check that event counts are not mislabeled as participant counts and that overlapping categories are identified.
- Confirm that captions and footnotes match the prespecified analysis and the actual output.
- Review the rendered package for omitted pages, stale dates, inconsistent version identifiers, and unintended audience content.
A package assembled manually from separate analyst files may be quick for a single review, but it increases the risk of inconsistent labels, stale outputs, and undocumented edits. A controlled programmatic workflow improves repeatability and makes it easier to regenerate the same package from the same snapshot. It still requires human review: automation cannot determine whether a display answers the intended question, whether a caveat is understandable, or whether the right audience receives the right set.
A further alternative is to provide every available output “for completeness.” This can obscure the planned review, increase the chance of inconsistent versions, and expose material beyond the intended scope. A focused package is preferable, with clearly identified supplemental material when justified and authorized. The limitation of any package remains important: it organizes evidence but does not guarantee data completeness, remove uncertainty, or replace DMC deliberation.
Common Mistake
Check Your Understanding
Answer each question, then compare your reasoning with the solutions below.
- A hypothetical disposition table reports 84 completed, 12 discontinued, and 24 ongoing participants among 120 randomized participants. Do the counts reconcile, and what percentage are ongoing?
- A deviation report lists 11 records affecting 7 distinct participants among 100 randomized participants. What participant-level percentage should be reported for having at least one deviation, and why is 11 the wrong numerator for that percentage?
- A planned efficacy display is for the prespecified 16-week assessment, but a 12-week output is available. What is the appropriate package action?
- A safety table’s total event count is larger than its number of participants with events. Is that automatically an error? State what the package should make clear.
Solutions. (1) The counts sum to \(84+12+24=120\), so they reconcile. The ongoing percentage is \(24/120\times100=20.00\%\). (2) Report \(7/100\times100=7.000\%\) of participants with at least one deviation. The 11 is a count of deviation records, and a participant may contribute more than one record. (3) Include the prespecified 16-week display if it can be generated under the approved rules; do not substitute the 12-week output. If the planned output is unavailable, state that and the reason. (4) No. One participant can experience multiple events. The table should clearly label whether it reports events or unique participants and specify the population and observation window.